The effects of adjuvant honey therapy on disease activity, lymphocyte function and lymphocyte subsets in patients with systemic lupus erythematosus (SLE)

Loading...
Thumbnail Image
Date
2010-06
Authors
Daud, Kamaliah Mohd
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objectives: To compare the effects of adjuvant tualang honey therapy versus conventional therapy alone on disease activity, lymphocyte functions and lymphocyte subsets in SLE patients. Methodology: Sixty SLE patients from Hospital Universiti Sains Malaysia were randomized into two equal groups, group 1 receiving conventional treatment with low dose steroid and cyclophosphamide or azathioprim, group 2 receiving same treatment in addition to tualang honey 20 gm twice a day. Disease activity was measured in all patients every 3 months by SLEDAI score, the function of T lymphocyte was determined at baseline and after 6 months by measuring the expression of 3 lymphocyte activation markers (HLADR, CD45RO and CD25). Enumeration of lymphocyte subsets (CD3, CD4, CDB, CD19, and CD16/56) was done at baseline and after 6 months. Results: The SLEDAI score was significantly decreased in honey group compared to non honey group after 3 and 6 months of follow up. There was a significant decrease in the expression of CD8CD45RO and CD8CD25 in honey group.There was a significant increase in CD3 and CD16/56 percentage in honey group after 6 months follow up. Conclusion: The use of honey therapy as adjuvant to conventional treatment in patients with SLE was found to be useful in suppressing disease activity and enhancing lymphocyte function and lymphocyte subsets.
Description
Keywords
Systemic lupus erythematosus
Citation